Meridian Bioscience reported $8.49M in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2545M 1153M
Atrion ATRI:US 9.48M 317K
Becton, Dickinson and BDX:US $ 495M 133M
Bio Rad Laboratories BIO:US $ 156.8M 32.02M
Cerulean Pharma CERU:US $ -12668940 3.51M
Cerus CERS:US $ -11126000 3.28M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Luminex LMNX:US $ 13.46M 2.96M
Meridian Bioscience VIVO:US $ 8.49M 7.19M
Myriad Genetics MYGN:US $ -79.9M 59.1M
Neogen NEOG:US $ 12.47M 9.28M
Orasure Technologies OSUR:US $ -13.01M 14.81M
Oxford Immunotec Global OXFD:US $ 0.28M 10.11M
Quidel QDEL:US $ 281.84M 258.54M
Rockwell Medical RMTI:US $ -6.97M 0.85M
Sientra SIEN:US -11694000 2.54M
Staar Surgical STAA:US $ 7.84M 2.81M
Thermo Fisher Scientific TMO:US $ 2278M 115M
Trinity Biotech TRIB:US $ 2.75M 2.53M